Olin Corporation (OLN - Free Report) provided an updated outlook for the second quarter and full year 2019.
The company expects to record net loss in the range of $15-$22 million in the second quarter and adjusted EBITDA of $200-$210 million. The updated guidance reflects more-than-expected decline in the prices of caustic soda, which fell roughly 3% quarter over quarter. Per the company, chlorine and chlorine derivative sales to titanium dioxide, refrigeration and agricultural customers were also lower than expected.
Olin stated that the results of the Epoxy business were negatively impacted by roughly $10 million-$15 million. This was mainly caused by lower production in Europe stemming from a utility supplier unplanned outage and persistent customer issues arising from the Intercontinental Terminals Company storage terminal fire in the Houston, TX area. Also, weaker-than-expected demand, especially from Europe affected the Epoxy results.
The company also expects charges to income for environmental investigatory and remedial activities to be roughly $20 million higher on a sequential basis. It also expects the second quarter to include around $40 million of higher planned maintenance turnaround costs compared with the first quarter.
Olin believes that results in the second half of 2019 to be stronger despite a challenging first half of the year. It expects caustic soda prices to improve during the second half. Considering the above factors, the company projects net income for 2019 between $128 million and $203 million. It anticipates corresponding adjusted EBITDA in the range of $1,075 million-$1,175 million.
Notably, the outlook provided by the company is preliminary and subject to change. Also, it does not reflect transactions or events that may occur in the remainder of 2019.
Shares of Olin have lost 28.3% in the past year compared with the industry’s 34.8% decline.
Zacks Rank & Key Picks
Olin currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the basic materials space are Materion Corporation (MTRN - Free Report) , Flexible Solutions International Inc (FSI - Free Report) and Fortescue Metals Group Ltd (FSUGY - Free Report) . These stocks currently sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Materion has an expected earnings growth rate of 30.3% for 2019. The company’s shares have gained 14.9% in the past year.
Flexible Solutions has projected earnings growth rate of 342.9% for the current year. The company’s shares have surged 161.8% in a year’s time.
Fortescue Metals has an estimated earnings growth rate of 294.2% for the current year. Its shares have rallied 92.5% in the past year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>